[Apheresis treatment for fulminant hepatitis].
作者信息
Tateishi Yoshihisa, Hirasawa Hiroyuki, Nitta Masakazu
机构信息
Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University.
出版信息
Nihon Rinsho. 2004 May;62 Suppl 5:462-6.
PMID:15197964
Abstract
摘要
相似文献
1
[Apheresis treatment for fulminant hepatitis].
Nihon Rinsho. 2004 May;62 Suppl 5:462-6.
2
[Liver failure].
Nihon Rinsho. 2004 May;62 Suppl 5:545-9.
3
[Blood purification for patients with chronic renal failure accompanied by severe liver disease].
Nihon Rinsho. 2004 Jun;62 Suppl 6:66-9.
4
Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease.
Intern Med. 2003 Oct;42(10):967-70. doi: 10.2169/internalmedicine.42.967.
5
[The evaluation for principles and clinical application of combined artificial liver therapy].
Zhonghua Gan Zang Bing Za Zhi. 2009 May;17(5):326-7.
6
Artificial liver support system in China: a review over the last 30 years.
Ther Apher Dial. 2006 Apr;10(2):160-7. doi: 10.1111/j.1744-9987.2006.00358.x.
7
Prolonged artificial liver support in a child with fulminant hepatic failure.
ASAIO J. 1996 May-Jun;42(3):233-5.
8
HBV-related fulminant hepatic failure: successful intensive medical therapy in a candidate for liver transplantation.
J Gastroenterol. 2001 May;36(5):350-3. doi: 10.1007/s005350170103.
9
Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation.
Intern Med. 2003 Oct;42(10):920-1. doi: 10.2169/internalmedicine.42.920.
10
Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation.
Transplant Proc. 2009 Jan-Feb;41(1):259-61. doi: 10.1016/j.transproceed.2008.10.058.
Zotero 插件